Glutamine in Preventing Acute Diarrhea in Patients With Pelvic Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

129

Participants

Timeline

Start Date

February 28, 1998

Primary Completion Date

May 31, 2003

Study Completion Date

June 30, 2003

Conditions
Cancer
Interventions
DIETARY_SUPPLEMENT

glutamine

OTHER

placebo

Trial Locations (18)

48106

CCOP - Ann Arbor Regional, Ann Arbor

55805

CCOP - Duluth, Duluth

55905

Mayo Clinic Cancer Center, Rochester

56303

CentraCare Clinic, Saint Cloud

58122

CCOP - Merit Care Hospital, Fargo

58501

Quain & Ramstad Clinic, P.C., Bismarck

61602

CCOP - Illinois Oncology Research Association, Peoria

61801

CCOP - Carle Cancer Center, Urbana

68131

CCOP - Missouri Valley Cancer Consortium, Omaha

85259-5404

CCOP - Scottsdale Oncology Program, Scottsdale

52403-1206

CCOP - Cedar Rapids Oncology Project, Cedar Rapids

10309-1016

CCOP - Iowa Oncology Research Association, Des Moines

51101-1733

Siouxland Hematology-Oncology, Sioux City

67214-3882

CCOP - Wichita, Wichita

43623-3456

CCOP - Toledo Community Hospital Oncology Program, Toledo

17822-2001

CCOP - Geisinger Clinical and Medical Center, Danville

57105-1080

CCOP - Sioux Community Cancer Consortium, Sioux Falls

S4S 6X3

Saskatchewan Cancer Agency, Regina

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Alliance for Clinical Trials in Oncology

OTHER

NCT00003170 - Glutamine in Preventing Acute Diarrhea in Patients With Pelvic Cancer | Biotech Hunter | Biotech Hunter